|
7th Peds Wk: Atazanavir Pharmacokinetics-Pharmacodynamics in HIV-1-Infected Children Aged 3 Months to <11 Years Treated With Atazanavir Powder/Ritonavir Liquid: PRINCE-1 & -2 Studies
|
|
|
Reported by Jules Levin
7th International Workshop on HIV Pediatrics, July 17-18, 2015, Vancouver, British Columbia, Canada
H. Sevinsky1, L. Zaru2, R. Wang2, X. Xu1, C. Pikora3, T. Correll1, T. Eley1
1Bristol-Myers Squibb, Princeton, NJ, USA; 2Bristol-Myers Squibb, Hopewell, NJ, USA; 3Bristol-Myers Squibb, Wallingford, CT, USA
![IAS1.gif](../images/080315/080315-8/IAS1.gif)
![IAS2.gif](../images/080315/080315-8/IAS2.gif)
![IAS3.gif](../images/080315/080315-8/IAS3.gif)
![IAS4.gif](../images/080315/080315-8/IAS4.gif)
![IAS5.gif](../images/080315/080315-8/IAS5.gif)
![IAS6.gif](../images/080315/080315-8/IAS6.gif)
![IAS7.gif](../images/080315/080315-8/IAS7.gif)
|
|
|
|
|
|
|